Skip to content
Study details
Enrolling now

Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis

University of Kansas Medical Center
NCT IDNCT06428006ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

70

Study length

about 2.8 years

Ages

18–65

Locations

1 site in KS

What this study is about

Researchers are testing whether cognitive behavioral therapy for insomnia (CBT-I) can help people with multiple sclerosis improve their sleep and overall well-being. The trial will compare CBT-I to a control group, and also look at what factors might make some people more likely to benefit from the treatment.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Cognitive behavioral therapy for insomnia
  • 2.Participate in Sleep and lifestyle education

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Insomnia Severity Index (ISI)

Secondary: Epworth Sleepiness Scale (ESS), Fatigue Severity Scale (FSS), Modified Fatigue Impact Scale (MFIS), Pittsburgh Sleep Quality Index (PSQI)

Procedures

therapy

Body systems

Neurology